[Federal Register Volume 64, Number 158 (Tuesday, August 17, 1999)]
[Notices]
[Page 44738]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-21263]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability and Injury Prevention and Control Special
Emphasis Panel: Intervention Research Addressing the Primary and
Secondary Prevention Needs of HIV-Seropositive Injection Drug Users
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting.
Name: Disease, Disability and Injury Prevention and Control
Special Emphasis Panel: Intervention Research Addressing the Primary
and Secondary Prevention Needs of HIV-Seropositive Injection Drug
Users, Program Announcement #99090.
Times and Dates: 8:30 a.m.-9:00 a.m., August 26, 1999 (Open);
9:00 a.m.-4:30 p.m., August 26, 1999 (Closed).
Place: CDC, National Center for HIV, STD and TB Prevention,
Executive Park, Building 57, Fifth Floor Conference Room, Atlanta,
GA 30329.
Status: Portions of the meeting will be closed to the public in
accordance with provisions set forth in section 552b(c)(4) and (6),
Title 5 U.S.C., and the Determination of the Associate Director for
Management and Operations, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to
Program Announcement #99090.
Contact Person for More Information: Beth Wolfe, Prevention
Support Office, National Center for HIV, STD, and TB Prevention,
CDC, Corporate Square Office Park, 11 Corporate Square Boulevard, M/
S E07, Atlanta, Georgia 30329, telephone 404/639-8025, e-mail
EOW1@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for the both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Dated: August 9, 1999.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 99-21263 Filed 8-12-99; 1:42 pm]
BILLING CODE 4163-18-P
